≡

Recombinant N-cadherin (NCAD)

CDw325; CD325; CDHN; CDH2; Cadherin 2 Type 1; N-Cadherin

  • Product No.RPB481Ra01
  • Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane
  • Predicted Molecular Mass14.3kDa
  • Accurate Molecular Mass18kDa(Analysis of differences refer to the manual)
  • Residues & TagsAsp295~Pro414 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Point4.7
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 180  US$ 450  US$ 900  US$ 2700  US$ 6750 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Toxicology Letters Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients. Pubmed: 23830989
British journal of haematology Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma. Pubmed: 23438504
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Elevated Cerebrospinal Fluid and Plasma N-Cadherin in Alzheimer Disease Pubmed: 32296844
Cell Biol Toxicol ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer 33566221
CELL BIOLOGY AND TOXICOLOGY Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence 33758996
Pharmacol Res DOC2B is a Negative Regulator of Wnt/β-catenin Signaling Pathway in Cervical Cancer Pubmed:35500882
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB481Ra02 Recombinant N-cadherin (NCAD) Positive Control; Immunogen; SDS-PAGE; WB.
RPB481Ra03 Recombinant N-cadherin (NCAD) Positive Control; Immunogen; SDS-PAGE; WB.
RPB481Ra01 Recombinant N-cadherin (NCAD) Positive Control; Immunogen; SDS-PAGE; WB.
PAB481Ra02 Polyclonal Antibody to N-cadherin (NCAD) WB; IHC; ICC; IP.
PAB481Ra03 Polyclonal Antibody to N-cadherin (NCAD) WB; IHC; ICC; IP.
PAB481Ra01 Polyclonal Antibody to N-cadherin (NCAD) WB; IHC; ICC; IP.
LAB481Ra71 Biotin-Linked Polyclonal Antibody to N-cadherin (NCAD) WB; IHC; ICC.